SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $17,204,000 | -67.2% | 626,040 | -60.5% | 0.14% | -67.8% |
| Q2 2019 | $52,485,000 | -4.0% | 1,586,125 | +1.6% | 0.44% | -7.5% |
| Q1 2019 | $54,680,000 | +5.2% | 1,560,515 | -0.3% | 0.48% | -9.7% |
| Q4 2018 | $51,995,000 | -22.4% | 1,565,185 | +17.6% | 0.53% | -11.1% |
| Q3 2018 | $67,001,000 | -11.7% | 1,330,705 | +4.9% | 0.59% | -19.2% |
| Q2 2018 | $75,905,000 | +30.0% | 1,268,255 | -0.5% | 0.74% | +16.5% |
| Q1 2018 | $58,402,000 | +20.8% | 1,275,155 | +5.1% | 0.63% | +15.4% |
| Q4 2017 | $48,329,000 | -1.8% | 1,212,785 | -1.4% | 0.55% | -5.9% |
| Q3 2017 | $49,199,000 | +53.0% | 1,229,975 | +64.9% | 0.58% | +47.8% |
| Q2 2017 | $32,149,000 | – | 745,917 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |